CV Sciences, Inc. (OTCMKTS:CVSI – Get Free Report) saw a large decrease in short interest in September. As of September 15th, there was short interest totaling 6,360 shares, a decrease of 93.9% from the August 31st total of 103,431 shares. Currently, 0.0% of the company’s stock are sold short. Based on an average trading volume of 883,978 shares, the days-to-cover ratio is currently 0.0 days.
CV Sciences Stock Down 6.2%
CVSI traded down $0.00 on Friday, hitting $0.01. The company had a trading volume of 153,020 shares, compared to its average volume of 865,180. The company’s fifty day moving average price is $0.02 and its 200 day moving average price is $0.03. CV Sciences has a 1-year low of $0.01 and a 1-year high of $0.10.
CV Sciences Company Profile
CV Sciences, Inc is a consumer wellness company focused on hemp-derived cannabidiol (CBD) products. The company develops, manufactures and markets products intended to support general wellness, with its offerings sold primarily under the PlusCBD brand.
The PlusCBD portfolio has included CBD oils and tinctures, softgels, gummies and other ingestible products, as well as topical formulations and products for pets. CV Sciences has emphasized research, product development and quality standards in the formulation and testing of its hemp-derived products.
CV Sciences distributes its products through e-commerce, specialty retailers and other consumer channels, primarily serving the U.S.
Further Reading
- Five stocks we like better than CV Sciences
- Cracker Barrel Stock Is Rallying Again, But the Turnaround Still Has a Traffic Problem
- Oracle’s Force Majeure Notice Exposes a Bigger Problem for the AI Build-Out
- Oil May Be Stronger Than It Looks—And Diamondback Is on Sale
- BlackBerry Shifts Gears With Coretura Deal
Receive News & Ratings for CV Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CV Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
